Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Igual-Rouilleault, A.C. (Alba Cristina) | - |
dc.creator | Soriano, I. (Ignacio) | - |
dc.creator | Quan, P.L. (Paola Leonor) | - |
dc.creator | Fernandez-Montero, A. (Alejandro) | - |
dc.creator | Elizalde, A. (Arlette) | - |
dc.creator | Pina, L. (Luis) | - |
dc.date.accessioned | 2022-08-04T10:16:44Z | - |
dc.date.available | 2022-08-04T10:16:44Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Igual-Rouilleault, A.C. (Alba Cristina); Soriano, I. (Ignacio); Quan, P.L. (Paola Leonor); et al. "Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation". European Radiology. (32), 2022, 3199 - 3206 | es |
dc.identifier.issn | 1432-1084 | - |
dc.identifier.uri | https://hdl.handle.net/10171/63873 | - |
dc.description.abstract | Objectives This study was conducted in order to investigate COVID-19 vaccine influence on unilateral axillary lymph nodes, comparing nodal basal features with their characteristics after the first and second vaccination dose. Methods Ninety-one volunteer employees from our center who participated in the BNT162b2 (Pfizer-BioNTech) vaccination campaign were prospectively recruited. A total of three axillary ultrasound evaluations of the ipsilateral vaccinated arm were performed: before vaccination, the week after the first dose and the week after the second dose. The following findings were recorded: the total number of visible nodes, the maximum measurements of the diameter and cortex, Bedi’s classification, and color Doppler evaluation. The collected data were compared using paired-sample Student’s t-test for quantitative continuous variables and Wilcoxon rank-sum test for ordinal variables. Additional analyses were performed after classifying patients according to the previous history of COVID-19 disease. Differences among both groups were evaluated with the Mann–Whitney U test. Variables with a p value < 0.05 were considered statistically significant. Results Comparative analyses between the three US examinations showed a statistically significant augmentation of total visible nodes, maximum diameter, cortical thickness, grade of Bedi’s classification, and Doppler signal (p < 0.001). Analyses between patients with and without previous COVID-19 infection showed a higher lymph node response in naïve patients compared to those who were previously infected. Conclusions According to our results, both doses of COVID-19 vaccine induced an increase of all axillary lymph node parameters with statistically significant differences, especially in coronavirus-naïve patients. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Springer | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | COVID-19 | es_ES |
dc.subject | mRNA vaccine | es_ES |
dc.subject | Unilateral axillary lymphadenopathy | es_ES |
dc.subject | Ultrasound | es_ES |
dc.title | Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.description.note | This article is licensed under a Creative Commons Attribution 4.0 International License | es_ES |
dc.identifier.doi | 10.1007/s00330-021-08309-7 | - |
dadun.citation.endingPage | 3206 | es_ES |
dadun.citation.number | 32 | es_ES |
dadun.citation.publicationName | European Radiology | es_ES |
dadun.citation.startingPage | 3199 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.